Sign in / Join Now
ETFs & Funds
at $40 looks very attractive.
Getting killed on this position. 3-for-2 split into hell. Looks like market wants to value this as a pharma. Need an exit at 55. Maybe 2019.
Add a reply...
Latest StockTalks »
people get INSY breaking news and analysis by email alert.
Get email alerts on INSY »
Insys Therapeutics, Inc.
Get latest price
From other sites
Piper Jaffray On FDA Approval Of Insys Therapeutics' Anorexia Drug Syndros
at Benzinga (Jul 7, 2016)
Mid-Afternoon Market Update: Dow Falls 140 Points; Insys Therapeutics Shares Surge Following FDA Approval of Syndros
at Benzinga (Jul 5, 2016)
What Falling Estimates & Price Mean for INSYS Therapeutics (INSY)
at Zacks.com (Apr 15, 2016)
INSYS Therapeutics (INSY) Looks Good: Stock Up 11.4%
at Zacks.com (Mar 15, 2016)
Insys Therapeutics : INVESTOR NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm
at 4-traders.com (Feb 8, 2016)